Ioxaglate Versus Iodixanol for the Prevention of Contrast-induced Nephropathy in High-risk Patients (IDPC Trial)

NCT02991742 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2262

Last updated 2016-12-14

No results posted yet for this study

Summary

Contrast media-induced nephropathy following diagnostic and therapeutic cardiac catheterization.

Conditions

  • Acute Kidney Failure

Interventions

OTHER

contrast media

Compare 2 contrast media

Sponsors & Collaborators

  • Instituto Dante Pazzanese de Cardiologia

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2016-12-31
Completion
2020-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02991742 on ClinicalTrials.gov